Syncell
Innovative spatial biology solutions using AI-guided photolabeling for precise 3D biospecimen analysis.
Employees
Enterprise value
$60—90m
Get premium to view all results
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | investor investor | €0.0 | round |
| N/A | €0.0 | round | |
| N/A | €0.0 | round | |
| N/A | €0.0 | round | |
* | $15.0m | Series A | |
| Total Funding | 000k | ||
Related Content
Notes (0)
More about Syncell
EditMade with AI
SYNCELL is a startup with the pioneering optoproteomics technology that turns a microscope into a "microscoop" to pick up proteins at specified locations. Integrating microscopy, deep learning, mechatronics, optics, photochemistry, biochemistry, and mass spectrometry with years of development, optoproteomics technology is expected to be indispensable for next-generation biological research, pushing our current limit of whole cell DNA/RNA studies to a new horizon of highly-anticipated whole cell protein studies.
Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads
Tech stack
Tech stackLearn more about the technologies and tools that this company uses.